Experimental Drug, Cytisinicline, May Help Folks Kick the Vaping Habit
By Dennis Thompson HealthDay Reporter
TUESDAY, May 7, 2024 -- An experimental anti-nicotine drug appears to help people quit vaping, a new study says.
Cytisinicline is a naturally occurring plant-based substance that binds to nicotine receptors in the brain, reducing a person’s cravings, researchers said.
The drug has been shown effective in helping people quit smoking, even though it’s not yet approved by the U.S. Food and Drug Administration (FDA).
Now, new clinical trial results show that vapers taking cytisinicline tablets were more than twice as likely to successfully stop using e-cigarettes after 9 to 12 weeks.
“No medication has been approved by the FDA for vaping cessation in the United States,” said lead researcher Dr. Nancy Rigotti, director of Massachusetts General Hospital’s Tobacco Research and Treatment Center. “Our study indicates that cytisinicline might be an option to fill this gap and help adult vapers to stop using e-cigarettes.”
About 11 million U.S. adults use nicotine-laced e-cigarettes, and about half want to stop but are too hooked to quit.
For the clinical trial, 160 adults who vape nicotine but don’t smoke were randomly assigned to take cytisinicline or a placebo for 12 weeks, along with support therapy to quit.
Nearly 32% of those taking cytisinicline had successfully quit by the end of the trial, compared with 15% of those taking a placebo.
The results jibe with those of earlier trials that tested the drug’s ability to help people quit smoking, researchers said.
“The results of our study need to be confirmed in a larger trial with longer follow-up, but they are promising,” Rigotti said in a news release.
The new clinical trial results were published May 6 in JAMA Internal Medicine.
Sources
- Massachusetts General Hospital, news release, May 6, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Parents' Vaping Might Help Spur Eczema in Kids
THURSDAY, May 23, 2024 -- A mom or dad who vapes at home might be setting their child up for eczema, new research suggests. In a study involving data from over 35,000 U.S...
TikTok: Ground Zero for Vaping Sales to Kids
THURSDAY, May 23, 2024 -- TikTok is full of fun memes, pranks, dances and challenges -- and illicit vaping product sales targeting teenagers, a new study reports. Advertising and...
Vaping After Quitting Smoking Keeps Lung Cancer Risk High
TUESDAY, May 21, 2024 -- If you've quit smoking and have switched to vaping instead, your odds for lung cancer won't fall as steeply as if you quit nicotine altogether, new...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
